Literature DB >> 19705237

Radiotherapy for metastatic brain tumors.

Yuta Shibamoto1, Chikao Sugie, Hiromitsu Iwata.   

Abstract

Radiation therapy has been the most important treatment for patients with brain metastases. With the development of stereotactic irradiation, conventional radiotherapy is being employed less often. However, whole-brain radiation therapy (WBRT) is still the mainstay of treatment for multiple brain metastases. This article reviews the results of conventional radiotherapy for brain metastases, and discusses optimal treatment, including fractionation schedules and combination with stereotactic irradiation, and the effects on neurocognitive functions. The authors conclude that WBRT with 30 Gy in ten fractions is no longer optimal for every patient with multiple brain metastases. WBRT employing appropriate fractionation schedules with or without stereotactic boost should be considered, depending on the patient's condition, disease status, and expected period of life.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19705237     DOI: 10.1007/s10147-009-0915-2

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  54 in total

Review 1.  Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time.

Authors:  Anne W M Lee; Dora L W Kwong; Sing Fai Leung; Stewart Y Tung; Wai Man Sze; Jonathan S T Sham; Peter M L Teo; To Wai Leung; Po Man Wu; Rick Chappell; Lester J Peters; John F Fowler
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-05-01       Impact factor: 7.038

2.  Neural stem cell-preserving external-beam radiotherapy of central nervous system malignancies.

Authors:  Igor J Barani; Laurie W Cuttino; Stanley H Benedict; Dorin Todor; Edward A Bump; Yan Wu; Theodore D Chung; William C Broaddus; Peck-Sun Lin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-04-30       Impact factor: 7.038

3.  Memory function before and after whole brain radiotherapy in patients with and without brain metastases.

Authors:  Grit Welzel; Katharina Fleckenstein; Jörg Schaefer; Brigitte Hermann; Uta Kraus-Tiefenbacher; Sabine K Mai; Frederik Wenz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-04-28       Impact factor: 7.038

4.  Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases.

Authors:  C Christodoulou; D Bafaloukos; P Kosmidis; E Samantas; A Bamias; P Papakostas; A Karabelis; C Bacoyiannis; D V Skarlos
Journal:  Ann Oncol       Date:  2001-02       Impact factor: 32.976

Review 5.  Radiotherapeutic management of brain metastases: a systematic review and meta-analysis.

Authors:  May N Tsao; Nancy S Lloyd; Rebecca K S Wong; Eileen Rakovitch; Edward Chow; Normand Laperriere
Journal:  Cancer Treat Rev       Date:  2005-06       Impact factor: 12.111

6.  Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trial. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) and the European Organization for Research and Treatment of Cancer (EORTC)

Authors:  A Gregor; A Cull; R J Stephens; J A Kirkpatrick; J R Yarnold; D J Girling; F R Macbeth; R Stout; D Machin
Journal:  Eur J Cancer       Date:  1997-10       Impact factor: 9.162

7.  A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104.

Authors:  K J Murray; C Scott; H M Greenberg; B Emami; M Seider; N L Vora; C Olson; A Whitton; B Movsas; W Curran
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-10-01       Impact factor: 7.038

Review 8.  The role of radiation therapy in the treatment of brain metastases.

Authors:  L R Coia
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

Review 9.  Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy.

Authors:  J R Crossen; D Garwood; E Glatstein; E A Neuwelt
Journal:  J Clin Oncol       Date:  1994-03       Impact factor: 44.544

10.  Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial.

Authors:  Christina A Meyers; Jennifer A Smith; Andrea Bezjak; Minesh P Mehta; James Liebmann; Tim Illidge; Ian Kunkler; Jean-Michel Caudrelier; Peter D Eisenberg; Jacobus Meerwaldt; Ross Siemers; Christian Carrie; Laurie E Gaspar; Walter Curran; See-Chun Phan; Richard A Miller; Markus F Renschler
Journal:  J Clin Oncol       Date:  2004-01-01       Impact factor: 44.544

View more
  12 in total

1.  Early volumetric change and treatment outcome of metastatic brain tumors after external beam radiotherapy: differential radiotherapy for brain metastasis.

Authors:  D S Lee; Y S Kim; C G Lee; J H Lim; C-O Suh; H J Kim; J Cho
Journal:  Clin Transl Oncol       Date:  2013-02-14       Impact factor: 3.405

2.  Fractionated stereotactic radiotherapy for metastatic brain tumors that recurred after gamma knife radiosurgery results in acceptable toxicity and favorable local control.

Authors:  Akifumi Miyakawa; Yuta Shibamoto; Shinya Takemoto; Toru Serizawa; Shinya Otsuka; Tatsuo Hirai
Journal:  Int J Clin Oncol       Date:  2016-11-08       Impact factor: 3.402

3.  Increases in the number of brain metastases detected at frame-fixed, thin-slice MRI for gamma knife surgery planning.

Authors:  Aiko Nagai; Yuta Shibamoto; Yoshimasa Mori; Chisa Hashizume; Masahiro Hagiwara; Tatsuya Kobayashi
Journal:  Neuro Oncol       Date:  2010-09-23       Impact factor: 12.300

4.  Baicalein attenuates impaired hippocampal neurogenesis and the neurocognitive deficits induced by γ-ray radiation.

Authors:  Shin Bi Oh; Hee Ra Park; Young Jung Jang; Seon Young Choi; Tae Gen Son; Jaewon Lee
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

5.  Low-dose Gamma Knife radiosurgery plus whole-brain radiation therapy for patients with 5 or more brain metastases with or without meningeal dissemination.

Authors:  Akifumi Miyakawa; Yuta Shibamoto; Shinya Takemoto; Tatsuo Hirai; Toru Serizawa
Journal:  Int J Clin Oncol       Date:  2018-08-11       Impact factor: 3.402

Review 6.  Evolution of multidisciplinary brain metastasis management: case study and literature review.

Authors:  Rovel Colaco; Pierre Martin; Veronica Chiang
Journal:  Yale J Biol Med       Date:  2015-06-01

7.  Treatment of single or multiple brain metastases by hypofractionated stereotactic radiotherapy using helical tomotherapy.

Authors:  Aiko Nagai; Yuta Shibamoto; Masanori Yoshida; Koichi Wakamatsu; Yuzo Kikuchi
Journal:  Int J Mol Sci       Date:  2014-04-22       Impact factor: 5.923

8.  Simulational study of a dosimetric comparison between a Gamma Knife treatment plan and an intensity-modulated radiotherapy plan for skull base tumors.

Authors:  Hisato Nakazawa; Yoshimasa Mori; Masataka Komori; Takahiko Tsugawa; Yuta Shibamoto; Tatsuya Kobayashi; Chisa Hashizume; Yukio Uchiyama; Masahiro Hagiwara
Journal:  J Radiat Res       Date:  2013-12-17       Impact factor: 2.724

9.  Compatibility of the repairable-conditionally repairable, multi-target and linear-quadratic models in converting hypofractionated radiation doses to single doses.

Authors:  Hiromitsu Iwata; Naruhiro Matsufuji; Toshiyuki Toshito; Takashi Akagi; Shinya Otsuka; Yuta Shibamoto
Journal:  J Radiat Res       Date:  2012-10-16       Impact factor: 2.724

10.  Percutaneous fiducial marker placement under CT fluoroscopic guidance for stereotactic body radiotherapy of the lung: an initial experience.

Authors:  Kengo Ohta; Masashi Shimohira; Hiromitsu Iwata; Takuya Hashizume; Hiroyuki Ogino; Akifumi Miyakawa; Taro Murai; Yuta Shibamoto
Journal:  J Radiat Res       Date:  2013-04-21       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.